Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #58369 on NorthWest Biotherapeutics Inc (NWBO)
Jack2479
04/07/16 6:51 PM
#58372 RE: Ready4bluesky #58369
CherryTree1
04/07/16 7:32 PM
#58396 RE: Ready4bluesky #58369
30:37 I think that in conclusion immunotherapy is an exciting new field It may likely be relevant for glioblastoma in the near future. Although there are a lot of on going clinical trials going on right now Not all glioblastomas are likely to be sensitive. I think t There are some subtypes ahhh more likely to respond to an immune based therapy We got to learn how to predict. Some of these patients are likely to have incomplete tumor resections from the clinical side. This is hard to treat because of the adaptive immune resistance that develops and combinatorial strategies are probably likely to be important. The identification of patient specific neoantigens I am sure is going to be relevant. The ability to be able to do it in a straight forward fashion that you can do it to make a difference for patients is really what the future is going to hold. 31:38